Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
In the latest session, Autolus Therapeutics plc ADR (NASDAQ: AUTL) closed at $1.82 down -2.67% from its previous closing price of $1.87. In other words, the price has decreased by -$2.67 from its previous closing price. On the day, 0.99 million shares were traded. AUTL stock price reached its highest trading level at $1.91 during the session, while it also had its lowest trading level at $1.79.
Ratios:
For a deeper understanding of Autolus Therapeutics plc ADR’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 13.64 and its Current Ratio is at 13.64. In the meantime, Its Debt-to-Equity ratio is 0.63 whereas as Long-Term Debt/Eq ratio is at 0.62.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Goldman on November 18, 2024, Upgraded its rating to Buy and sets its target price to $7.60 from $7 previously.
On November 15, 2024, Redburn Atlantic Upgraded its rating to Buy which previously was Neutral but kept the price unchanged to $13.
On November 09, 2023, Deutsche Bank started tracking the stock assigning a Buy rating and target price of $10.Deutsche Bank initiated its Buy rating on November 09, 2023, with a $10 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Sep 16 ’24 when Martin Pule bought 698,741 shares for $4.23 per share.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AUTL now has a Market Capitalization of 484342048 and an Enterprise Value of 128446472. For the stock, the TTM Price-to-Sale (P/S) ratio is 48.00 while its Price-to-Book (P/B) ratio in mrq is 1.02. Its current Enterprise Value per Revenue stands at 12.729 whereas that against EBITDA is -0.609.
Stock Price History:
The Beta on a monthly basis for AUTL is 1.98, which has changed by -0.70645165 over the last 52 weeks, in comparison to a change of 0.09589827 over the same period for the S&P500. Over the past 52 weeks, AUTL has reached a high of $6.62, while it has fallen to a 52-week low of $1.68. The 50-Day Moving Average of the stock is -13.23%, while the 200-Day Moving Average is calculated to be -45.25%.
Shares Statistics:
For the past three months, AUTL has traded an average of 1.31M shares per day and 1196180 over the past ten days. A total of 266.12M shares are outstanding, with a floating share count of 240.31M. Insiders hold about 9.70% of the company’s shares, while institutions hold 53.78% stake in the company. Shares short for AUTL as of 1740700800 were 9104667 with a Short Ratio of 6.96, compared to 1738281600 on 9108530. Therefore, it implies a Short% of Shares Outstanding of 9104667 and a Short% of Float of 4.62.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
